Zobrazeno 1 - 10
of 19 144
pro vyhledávání: '"QUINIDINE"'
Autor:
Johnston CU; Department of Biological Sciences, Simon Fraser University, 8888 University Drive Burnaby, British Columbia, Canada., Kennedy CJ; Department of Biological Sciences, Simon Fraser University, 8888 University Drive Burnaby, British Columbia, Canada. ckennedy@sfu.ca.
Publikováno v:
Fish physiology and biochemistry [Fish Physiol Biochem] 2024 Dec; Vol. 50 (6), pp. 2149-2164. Date of Electronic Publication: 2024 Jul 19.
Autor:
Khan AN; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut., Murphy KS; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas., Tampi RR; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.; Department of Psychiatry, Creighton University School of Medicine, Omaha, Nebraska.; Corresponding Author: Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP, Department of Psychiatry, Creighton University Education, Bldg, 7710 Mercy Rd, Ste 601, Omaha, NE 68124-2370 (rajesh.tampi@gmail.com).
Publikováno v:
The primary care companion for CNS disorders [Prim Care Companion CNS Disord] 2024 Nov 14; Vol. 26 (6). Date of Electronic Publication: 2024 Nov 14.
Autor:
Boinpally R; Clinical Pharmacology, AbbVie, North Chicago, IL, USA., Borbridge L; Bioanalysis, AbbVie, Irvine, CA, USA., Wangsadipura V; Data and Statistical Sciences, AbbVie, Irvine, CA, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Aug; Vol. 13 (8), pp. 930-937. Date of Electronic Publication: 2024 May 03.
Autor:
Leduc L; Department of Clinical Studies, New Bolton Center, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA., Abraham M; Department of Clinical Studies, New Bolton Center, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA., Slack J; Department of Clinical Studies, New Bolton Center, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
Publikováno v:
Journal of veterinary internal medicine [J Vet Intern Med] 2024 Sep-Oct; Vol. 38 (5), pp. 2783-2789. Date of Electronic Publication: 2024 Aug 30.
Autor:
Boulay E; Charles River Laboratories, Laval, Quebec, Canada; GREPAQ (Groupe de recherche en pharmacologie animale du Québec), Université de Montréal, St-Hyacinthe, Québec, Canada., Authier S; Charles River Laboratories, Laval, Quebec, Canada; GREPAQ (Groupe de recherche en pharmacologie animale du Québec), Université de Montréal, St-Hyacinthe, Québec, Canada. Electronic address: simonauthier@hotmail.com., Bartko T; Labcorp Early Development Laboratories Inc, Madison, WI, USA., Greiter-Wilke A; Roche Pharma Research and Early Development, Basel, Switzerland., Leishman D; Eli Lilly and Company, Indianapolis, IN, USA., Li D; Pfizer, Inc, Groton, CT, USA., Nichols JV; Labcorp Early Development Laboratories Inc, Madison, WI, USA., Pierson J; Health and Environmental Sciences Institute (HESI), Washington, DC, USA., Rossman EI; GSK, King of Prussia, PA, USA., Valentin JP; UCB Biopharma SPRL, Brussels, Belgium., Vicente J; Center for Drug Evaluation and Research, US Food & Drug Administration (FDA), Silver Spring, MD, USA., Walisser J; Labcorp Early Development Laboratories Inc, Madison, WI, USA., Troncy E; GREPAQ (Groupe de recherche en pharmacologie animale du Québec), Université de Montréal, St-Hyacinthe, Québec, Canada., Wisialowski TA; Pfizer, Inc, Groton, CT, USA.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2024 Sep-Oct; Vol. 129, pp. 107543. Date of Electronic Publication: 2024 Jul 15.
Autor:
Gras M; Reference Center for Rare Epilepsies, Department of Pediatric Neurology, Necker Enfants Malades Hospital, APHP, Member of EPICARE, Université Paris Cité, Paris, France.; Institut Imagine, INSERM U1163, Université Paris Cite, Paris, France., Bearden D; Division of Child Neurology, Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA., West J; KCNT1 Epilepsy Foundation (501C3). President. Co-Founder. Director of Clinical Medicine, Newport Beach, California, USA., Nabbout R; Reference Center for Rare Epilepsies, Department of Pediatric Neurology, Necker Enfants Malades Hospital, APHP, Member of EPICARE, Université Paris Cité, Paris, France.; Institut Imagine, INSERM U1163, Université Paris Cite, Paris, France.
Publikováno v:
Epilepsia open [Epilepsia Open] 2024 Aug; Vol. 9 (4), pp. 1176-1191. Date of Electronic Publication: 2024 Jun 22.
Autor:
Rask-Madsen C; Translational Medicine and Clinical Pharmacology, Sanofi, Cambridge, MA, USA., Katragadda S; Department of Pharmacokinetics, Dynamics and Metabolism, Sanofi, Cambridge, MA, USA., Li M; Department of Pharmacokinetics, Dynamics and Metabolism, Sanofi, Bridgewater, NJ, USA., Ucpinar S; Department of Pharmacokinetics, Dynamics and Metabolism, Sanofi, Bridgewater, NJ, USA., Chinn L; Department of Pharmacokinetics, Dynamics and Metabolism, Sanofi, Bridgewater, NJ, USA., Arora P; Department of Clinical, Inflammation and Immunology, Sanofi, South San Francisco, CA, USA., Smith P; Integrated Drug Development, Certara, Parsippany, NJ, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Jun; Vol. 13 (6), pp. 590-600. Date of Electronic Publication: 2024 Apr 16.
Autor:
Woiwode U; Institute of Pharmaceutical Sciences, Pharmaceutical (Bio-)Analysis, University of Tübingen, Tübingen, Germany., Sievers-Engler A; Institute of Pharmaceutical Sciences, Pharmaceutical (Bio-)Analysis, University of Tübingen, Tübingen, Germany., Lämmerhofer M; Institute of Pharmaceutical Sciences, Pharmaceutical (Bio-)Analysis, University of Tübingen, Tübingen, Germany.
Publikováno v:
Electrophoresis [Electrophoresis] 2024 Jun; Vol. 45 (11-12), pp. 989-999. Date of Electronic Publication: 2023 Nov 02.
Autor:
Yuan T; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Wang Y; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Jin Y; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Yang H; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Xu S; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Zhang H; NHC and CAMS Key Laboratory of Medical Neurobiology, MOE Frontier Science Center for Brain Research and Brain-Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Zhejiang, China., Chen Q; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Li N; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Ma X; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Song H; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Peng C; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Geng Z; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Dong J; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Duan G; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Sun Q; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China., Yang Y; Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, United States., Yang F; NHC and CAMS Key Laboratory of Medical Neurobiology, MOE Frontier Science Center for Brain Research and Brain-Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Zhejiang, China.; Department of Biophysics, Kidney Disease Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China., Huang Z; State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.; IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.
Publikováno v:
ELife [Elife] 2024 Jan 30; Vol. 12. Date of Electronic Publication: 2024 Jan 30.
Autor:
Hayashi S; Preclinical Research Unit, Drug Research Division, Sumitomo Pharma Co, Ltd, Japan.; Drug Metabolism and Toxicology, Kanazawa University, Kanazawa, Japan., Kawaguchi H; Preclinical Research Unit, Drug Research Division, Sumitomo Pharma Co, Ltd, Japan., Watanabe T; Drug Research Division, Sumitomo Pharma Co, Ltd, Japan., Miyawaki I; Preclinical Research Unit, Drug Research Division, Sumitomo Pharma Co, Ltd, Japan., Fukami T; Drug Metabolism and Toxicology, Kanazawa University, Kanazawa, Japan.; WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kanazawa, Japan., Nakajima M; Drug Metabolism and Toxicology, Kanazawa University, Kanazawa, Japan.; WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kanazawa, Japan.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2024 Mar; Vol. 54 (3), pp. 107-115. Date of Electronic Publication: 2024 Jan 17.